BLUEADAPT: Reducing climate based health risks in blue environments. Adapting to the climate change impacts on coastal pathogens

BLUEADAPT：减少蓝色环境中基于气候的健康风险。

• 批准号: 10052955
• 金额: $ 200.73万
• 依托单位: UNIVERSITY OF EXETER
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10052955
• 关键词: BLUEADAPT; Reducing; climate; based; health

BlueAdapt brings together an interdisciplinary team of biologists, climate scientists, economists, epidemiologists, and public health experts to investigate and quantify the future health risks associated with selected coastal pathogens. BlueAdapt will provide tools to assess the impacts of policy responses and communicate the results to a wide audience, including both policymakers and the public. A conceptual framework will be developed around existing models of One Health and Ecological Public Health, to help wider engagement with the complex nature of the issue. Horizons scanning and downscaled climate modelling will feed into lab-based experiments and the development of simulations around how changes in climate variables, interacting with other environmental change, may influence the state of selected microbial pathogens of public health concern in coastal waters. Case studies will illustrate how One Health and Ecological Public Health concepts can be used to generate action and identify potential barriers to adaptation. Health impact assessment and cost-benefit analysis will inform appropriate action. BlueAdapt Innovation Slams and policy workshops will help deliver wider impact from the project including new-to-firm and new-to-market products and services.

Blueadapt汇集了一个跨学科的生物学家，气候科学家，经济学家，流行病学家和公共卫生专家，以调查和量化与选定的沿海病原体相关的未来健康风险。 Blueadapt将提供工具来评估政策响应的影响，并将结果传达给包括政策制定者和公众在内的广泛受众。将围绕一个健康和生态公共卫生的现有模型发展一个概念框架，以帮助更广泛地参与该问题的复杂性。地平线扫描和缩小的气候建模将进食基于实验室的实验，并开发围绕气候变量的变化与其他环境变化相互作用的模拟开发，可能会影响沿海水域中公共卫生关注的选定微生物病原体的状态。案例研究将说明如何使用一种健康和生态公共卫生概念来产生行动并确定适应的潜在障碍。健康影响评估和成本效益分析将为适当的行动提供依据。 BlueAdapt创新的大满贯和政策研讨会将有助于对该项目的更广泛影响，包括新的到公司和新的市场产品和服务。